Ohcanbohtosat - Gerald Schmid‐Bindert

  • Čájehuvvo 1 - 6 / 6
Aiddostahte ozu
  1. 1
    Erlotinib in the treatment of advanced non-small cell lung cancer: an update for clinicians

    Erlotinib in the treatment of advanced non-small cell lung cancer: an update for clinicians Dahkki Yongsheng Wang, Gerald Schmid‐Bindert, Caicun Zhou

    Almmustuhtton 2011
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    KRAS-Mutant non-small cell lung cancer: From biology to therapy

    KRAS-Mutant non-small cell lung cancer: From biology to therapy Dahkki Irene Ferrer, Jon Zugazagoitia, Stephan Herbertz, William J. John, Luis Paz‐Ares, Gerald Schmid‐Bindert

    Almmustuhtton 2018
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Incidental Pulmonary Nodules – What Do We Know in 2022

    Incidental Pulmonary Nodules – What Do We Know in 2022 Dahkki Gerald Schmid‐Bindert, Jens Vogel‐Claussen, S Gütz, Joana Fink, Hans Hoffmann, Martin Eichhorn, Felix J.F. Herth

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules

    High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules Dahkki Chunyan Wu, Chao Zhao, Yang Yang, Yayi He, Likun Hou, Xuefei Li, Guanghui Gao, Jingyun Shi, Shengxiang Ren, Haiqing Chu, Caicun Zhou, Jun Zhang, Gerald Schmid‐Bindert

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)

    A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1) Dahkki Suresh S. Ramalingam, Glenwood Goss, Rafael Rosell, Gerald Schmid‐Bindert, Bojan Zarić, Z. Andric, Igor Bondarenko, Д. В. Комов, Timur Cerić, Fadlo R. Khuri, Miroslav Samaržija, Enriqueta Felip, Tudor‐Eliade Ciuleanu, Vera Hirsh, S. Cindy, James Spicer, Ravi Salgia, Geoffrey I. Shapiro, Eric Sheldon, Florentina Teofilovici, Vojo Vukovic, Dean A. Fennell

    Almmustuhtton 2015
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort

    Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort Dahkki Oliver Gautschi, Julie Milia, Bastien Cabarrou, M.V. Bluthgen, Benjamin Besse, Egbert F. Smit, Juergen Wolf, Solange Peters, Martin Früh, Dieter Koeberle, Youssouf Oulkhouir, Martin Schüler, Alessandra Curioni‐Fontecedro, Benjamin Huret, M. Kerjouan, Sebastian Michels, Georg Pall, Sacha I. Rothschild, Gerald Schmid‐Bindert, Matthias Scheffler, Rémi Veillon, Luciano Wannesson, Joachim Diebold, Gérard Zalcman, Thomas Filleron, Julien Mazières

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: